More recently, Liao et al. (47) provided evidence that fibronectin silencing in gliomas is associated with disruption of the PI3K-AKT signaling pathway and subsequent inhibition of cell proliferation, as well as promotion of cell apoptosis and senescence. This evidence concerns the gene AKT1 and central nervous system cancer.